Cytokine-induced cell death in human oligodendroglial cell lines:: I.: Synergistic effects of IFN-γ and TNF-α on apoptosis

被引:98
作者
Buntinx, M
Moreels, M
Vandenabeele, F
Lambrichts, I
Raus, J
Steels, P
Stinissen, P
Ameloot, M
机构
[1] Limburgs Univ Ctr, Transit Univ Limburg, Biomed Onderzoeksinst, B-3590 Diepenbeek, Belgium
[2] Transit Univ Limburg, Sch Life Sci, B-3590 Diepenbeek, Belgium
关键词
oligodendrocyte; multiple sclerosis; HOG; MO3.13;
D O I
10.1002/jnr.20118
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Multiple sclerosis is a chronic inflammatory disease of the central nervous system. Myelin and oligodendrocytes are considered the major targets of injury caused by a cell-mediated immune response. There is circumstantial evidence that proinflammatory cytokines like tumor necrosis factor alpha (TNF-alpha) and interferon gamma (IFN-gamma) could have disease-promoting roles in multiple sclerosis (MS). In the present study, the cytotoxic effects of IFN-gamma and TNF-alpha on the human oligodendroglial cell lines human oligodendroglioma (HOG) and MO3.13 were analyzed. When the oligodendroglial cell lines were cultured in the presence of IFN-gamma or TNF-alpha, apoptotic cell death was observed in both cell lines after >24 hr incubation. Apoptosis was evidenced by a decrease in cell viability, apoptotic changes in cell and nucleus morphology, and disruption of the membrane asymmetry. Our data show that TNF-alpha and IFN-gamma induce apoptosis in a dose-dependent fashion in both oligodendroglial cell lines and that their synergistic effect results in enhanced cell death. Understanding the regulation of cell death pathways in oligodendrocytes is critical for protecting myelin-producing cells and their associated axons during injury in patients with MS. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:834 / 845
页数:12
相关论文
共 61 条
[41]  
Prineas J., 1997, GREENFIELDS NEUROPAT, P813
[42]   SPONTANEOUS INFLAMMATORY DEMYELINATING DISEASE IN TRANSGENIC MICE SHOWING CENTRAL NERVOUS SYSTEM-SPECIFIC EXPRESSION OF TUMOR-NECROSIS-FACTOR-ALPHA [J].
PROBERT, L ;
AKASSOGLOU, K ;
PASPARAKIS, M ;
KONTOGEORGOS, G ;
KOLLIAS, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (24) :11294-11298
[43]   The Norton Lecture: A review of the oligodendrocyte in the multiple sclerosis lesion [J].
Raine, CS .
JOURNAL OF NEUROIMMUNOLOGY, 1997, 77 (02) :135-152
[44]   MULTIPLE-SCLEROSIS - TNF REVISITED, WITH PROMISE [J].
RAINE, CS .
NATURE MEDICINE, 1995, 1 (03) :211-214
[45]  
Scurlock B, 1999, J NEUROSCI RES, V55, P514, DOI 10.1002/(SICI)1097-4547(19990215)55:4<514::AID-JNR11>3.3.CO
[46]  
2-M
[47]  
Selmaj K, 1998, EUR J IMMUNOL, V28, P2035, DOI 10.1002/(SICI)1521-4141(199806)28:06<2035::AID-IMMU2035>3.3.CO
[48]  
2-1
[49]   IDENTIFICATION OF LYMPHOTOXIN AND TUMOR-NECROSIS-FACTOR IN MULTIPLE-SCLEROSIS LESIONS [J].
SELMAJ, K ;
RAINE, CS ;
CANNELLA, B ;
BROSNAN, CF .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (03) :949-954
[50]  
SELMAJ K, 1991, J IMMUNOL, V147, P1522